Assessment and Treatment of Anxiety Disorders in Children and Adolescents

被引:19
|
作者
Connolly, Sucheta D. [1 ]
Suarez, Liza [1 ]
Sylvester, Carrie [2 ]
机构
[1] Univ Illinois, Med Ctr Chicago, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA
[2] Sound Mental Hlth, Seattle, WA 98112 USA
关键词
Childhood anxiety disorders; Screening; Assessment; CBT; Psychopharmacology; COGNITIVE-BEHAVIORAL THERAPY; SEROTONIN REUPTAKE INHIBITORS; PLACEBO-CONTROLLED TRIAL; SELECTIVE MUTISM; SOCIAL PHOBIA; PSYCHOMETRIC PROPERTIES; IMIPRAMINE TREATMENT; ALCOHOL DEPENDENCE; ADVERSE EVENTS; PRIMARY-CARE;
D O I
10.1007/s11920-010-0173-z
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This article reviews the current screening and assessment tools for anxiety disorders in children and adolescents, as well as evidence-based treatment interventions for these disorders. The following anxiety disorders are discussed: separation anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, social anxiety disorder (social phobia), and selective mutism. There are several well-studied screening and assessment tools to identify childhood anxiety disorders early and differentiate the various anxiety disorders. Evaluations of baseline somatic symptoms, severity, and impairment ratings of the anxiety disorders, and collecting ratings from several sources is clinically helpful in assessment and treatment follow-up. Cognitive-behavioral therapy (CBT) has been extensively studied and has shown good efficacy in treatment of childhood anxiety disorders. A combination of CBT and medication may be required for moderate to severely impairing anxiety disorders and may improve functioning better than either intervention alone. Selective serotonin reuptake inhibitors are currently the only medications that have consistently shown efficacy in treatment of anxiety disorders in children and adolescents. Despite proven efficacy, the availability of CBT in the community is limited. Current research is focusing on early identification of anxiety disorders in community settings, increasing the availability of evidence-based interventions, and modification of interventions for specific populations.
引用
收藏
页码:99 / 110
页数:12
相关论文
共 50 条
  • [41] Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
    Fairbanks, JM
    Pine, DS
    Tancer, NK
    Dummit, ES
    Kentgen, LM
    Martin, J
    Asche, BK
    Klein, RG
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1997, 7 (01) : 17 - 29
  • [42] The influence of comorbidity on treatment outcome for children and adolescents with anxiety disorders
    Rapee, RM
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 2003, 41 (01) : 105 - 112
  • [43] An overview of controlled studies of anxiety disorders treatment in children and adolescents
    Scott, RW
    Mughelli, K
    Deas, D
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2005, 97 (01) : 13 - 24
  • [44] Fluvoxamine for the treatment of anxiety disorders in children and adolescents. Reply
    Pine, DS
    Walkup, JT
    Greenhill, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06): : 466 - 467
  • [45] Pharmacotherapy for the treatment of anxiety disorders in children and adolescents: a sistematic review
    Moreira Maia, Carlos Renato
    Rohde, Luis Augusto
    [J]. REVISTA BRASILEIRA DE PSIQUIATRIA, 2007, 29 (01): : 72 - 79
  • [46] Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners
    Patel, Dilip R.
    Feucht, Cynthia
    Brown, Kelly
    Ramsay, Jessica
    [J]. TRANSLATIONAL PEDIATRICS, 2018, 7 (01) : 23 - 35
  • [47] Comorbid ADHD: Implications for the Treatment of Anxiety Disorders in Children and Adolescents
    Halldorsdottir, Thorhildur
    Ollendick, Thomas H.
    [J]. COGNITIVE AND BEHAVIORAL PRACTICE, 2014, 21 (03) : 310 - 322
  • [48] ASSESSMENT AND TREATMENT OF ANXIETY DISORDERS IN CHILDREN WITH A HISTORY OF MALTREATMENT
    Strawn, Jeffrey R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S88 - S88
  • [49] Evidence-based assessment of anxiety and its disorders in children and adolescents
    Silverman, WK
    Ollendick, TH
    [J]. JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, 2005, 34 (03): : 380 - 411
  • [50] A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents
    Susan M. Hawkridge
    Dan J. Stein
    [J]. Drug Safety, 1998, 19 : 283 - 297